ID   ECHP_HUMAN              Reviewed;         723 AA.
AC   Q08426; A8K6Y3; B4DWG3; D3DNU0; Q58EZ5;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 3.
DT   28-JUN-2023, entry version 214.
DE   RecName: Full=Peroxisomal bifunctional enzyme {ECO:0000305};
DE            Short=PBE;
DE            Short=PBFE;
DE   AltName: Full=L-bifunctional protein {ECO:0000303|PubMed:15060085};
DE            Short=LBP {ECO:0000303|PubMed:15060085};
DE   AltName: Full=Multifunctional enzyme 1;
DE            Short=MFE1;
DE   Includes:
DE     RecName: Full=Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase;
DE              EC=4.2.1.17 {ECO:0000269|PubMed:15060085};
DE              EC=5.3.3.8;
DE   Includes:
DE     RecName: Full=3-hydroxyacyl-CoA dehydrogenase;
DE              EC=1.1.1.35 {ECO:0000269|PubMed:15060085};
GN   Name=EHHADH {ECO:0000312|HGNC:HGNC:3247}; Synonyms=ECHD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANTS
RP   GLY-40; ARG-41; ILE-75; GLY-325; THR-598 AND PRO-606.
RC   TISSUE=Liver;
RX   PubMed=8188243; DOI=10.1006/geno.1994.1013;
RA   Hoefler G., Forstner M., McGuinness M.C., Hulla W., Hiden M., Krisper P.,
RA   Kenner L., Ried T., Lengauer C., Zechner R., Moser H.W., Chen G.L.;
RT   "cDNA cloning of the human peroxisomal enoyl-CoA hydratase: 3-hydroxyacyl-
RT   CoA dehydrogenase bifunctional enzyme and localization to chromosome
RT   3q26.3-3q28: a free left Alu Arm is inserted in the 3' noncoding region.";
RL   Genomics 19:60-67(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RA   Cherkaoui-Malki M., Surapureddi S., Yeldandi A.V., Rao S.M., Zhu Y.,
RA   Reddy J.K.;
RT   "Structural organization of gene for human peroxisomal enoyl-CoA
RT   hydratase/L-3-hydroxyacyl-CoA dehydrogenase: L-bifunctional enzyme (L-
RT   PBE).";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   THR-274.
RC   TISSUE=Placenta, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 502-723 (ISOFORMS 1/2), AND VARIANTS THR-598
RP   AND PRO-606.
RC   TISSUE=Liver;
RX   PubMed=1651711; DOI=10.1016/0006-291x(91)91003-u;
RA   Chen G.L., Balfe A., Erwa W., Hoefler G., Gaertner J., Aikawa J.,
RA   Chen W.W.;
RT   "Import of human bifunctional enzyme into peroxisomes of human hepatoma
RT   cells in vitro.";
RL   Biochem. Biophys. Res. Commun. 178:1084-1091(1991).
RN   [9]
RP   ASSOCIATION WITH PERIXOSOMAL DISORDERS.
RX   PubMed=3469675; DOI=10.1073/pnas.84.5.1425;
RA   Chen W.W., Watkins P.A., Osumi T., Hashimoto T., Moser H.W.;
RT   "Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy:
RT   distinction between X-linked adrenoleukodystrophy and neonatal
RT   adrenoleukodystrophy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:1425-1428(1987).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15060085; DOI=10.1194/jlr.m300512-jlr200;
RA   Ferdinandusse S., Denis S., Van Roermund C.W., Wanders R.J., Dacremont G.;
RT   "Identification of the peroxisomal beta-oxidation enzymes involved in the
RT   degradation of long-chain dicarboxylic acids.";
RL   J. Lipid Res. 45:1104-1111(2004).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-584, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   ACETYLATION AT LYS-165; LYS-171; LYS-346 AND LYS-584, ACTIVITY REGULATION,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF LYS-165; LYS-171;
RP   LYS-346 AND LYS-584.
RX   PubMed=20167786; DOI=10.1126/science.1179689;
RA   Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L.,
RA   Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L., Chin J.,
RA   Yang P., Chen X., Lei Q., Xiong Y., Guan K.L.;
RT   "Regulation of cellular metabolism by protein lysine acetylation.";
RL   Science 327:1000-1004(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-718, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-548, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   VARIANT FRTS3 LYS-3, CHARACTERIZATION OF VARIANT FRTS3 LYS-3, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=24401050; DOI=10.1056/nejmoa1307581;
RA   Klootwijk E.D., Reichold M., Helip-Wooley A., Tolaymat A., Broeker C.,
RA   Robinette S.L., Reinders J., Peindl D., Renner K., Eberhart K., Assmann N.,
RA   Oefner P.J., Dettmer K., Sterner C., Schroeder J., Zorger N., Witzgall R.,
RA   Reinhold S.W., Stanescu H.C., Bockenhauer D., Jaureguiberry G.,
RA   Courtneidge H., Hall A.M., Wijeyesekera A.D., Holmes E., Nicholson J.K.,
RA   O'Brien K., Bernardini I., Krasnewich D.M., Arcos-Burgos M., Izumi Y.,
RA   Nonoguchi H., Jia Y., Reddy J.K., Ilyas M., Unwin R.J., Gahl W.A.,
RA   Warth R., Kleta R.;
RT   "Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's
RT   syndrome.";
RL   N. Engl. J. Med. 370:129-138(2014).
CC   -!- FUNCTION: Peroxisomal trifunctional enzyme possessing 2-enoyl-CoA
CC       hydratase, 3-hydroxyacyl-CoA dehydrogenase, and delta 3, delta 2-enoyl-
CC       CoA isomerase activities. Catalyzes two of the four reactions of the
CC       long chain fatty acids peroxisomal beta-oxidation pathway (By
CC       similarity). Can also use branched-chain fatty acids such as 2-methyl-
CC       2E-butenoyl-CoA as a substrate, which is hydrated into (2S,3S)-3-
CC       hydroxy-2-methylbutanoyl-CoA (By similarity). Optimal isomerase for 2,5
CC       double bonds into 3,5 form isomerization in a range of enoyl-CoA
CC       species (Probable). Also able to isomerize both 3-cis and 3-trans
CC       double bonds into the 2-trans form in a range of enoyl-CoA species (By
CC       similarity). With HSD17B4, catalyzes the hydration of trans-2-enoyl-CoA
CC       and the dehydrogenation of 3-hydroxyacyl-CoA, but with opposite chiral
CC       specificity (PubMed:15060085). Regulates the amount of medium-chain
CC       dicarboxylic fatty acids which are essential regulators of all fatty
CC       acid oxidation pathways (By similarity). Also involved in the
CC       degradation of long-chain dicarboxylic acids through peroxisomal beta-
CC       oxidation (PubMed:15060085). {ECO:0000250|UniProtKB:P07896,
CC       ECO:0000250|UniProtKB:Q9DBM2, ECO:0000269|PubMed:15060085,
CC       ECO:0000305|PubMed:15060085}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3S)-3-hydroxyacyl-CoA = a (2E)-enoyl-CoA + H2O;
CC         Xref=Rhea:RHEA:16105, ChEBI:CHEBI:15377, ChEBI:CHEBI:57318,
CC         ChEBI:CHEBI:58856; EC=4.2.1.17;
CC         Evidence={ECO:0000269|PubMed:15060085};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16106;
CC         Evidence={ECO:0000305|PubMed:15060085};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 4-saturated-(3S)-3-hydroxyacyl-CoA = a (3E)-enoyl-CoA + H2O;
CC         Xref=Rhea:RHEA:20724, ChEBI:CHEBI:15377, ChEBI:CHEBI:58521,
CC         ChEBI:CHEBI:137480; EC=4.2.1.17;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20725;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3Z)-enoyl-CoA = a 4-saturated (2E)-enoyl-CoA;
CC         Xref=Rhea:RHEA:45900, ChEBI:CHEBI:85097, ChEBI:CHEBI:85489;
CC         EC=5.3.3.8; Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45901;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3E)-enoyl-CoA = a 4-saturated (2E)-enoyl-CoA;
CC         Xref=Rhea:RHEA:45228, ChEBI:CHEBI:58521, ChEBI:CHEBI:85097;
CC         EC=5.3.3.8; Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45229;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3S)-3-hydroxyacyl-CoA + NAD(+) = a 3-oxoacyl-CoA + H(+) +
CC         NADH; Xref=Rhea:RHEA:22432, ChEBI:CHEBI:15378, ChEBI:CHEBI:57318,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:90726; EC=1.1.1.35;
CC         Evidence={ECO:0000269|PubMed:15060085};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22433;
CC         Evidence={ECO:0000305|PubMed:15060085};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA = (2E)-2-methylbut-2-
CC         enoyl-CoA + H2O; Xref=Rhea:RHEA:31119, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57312, ChEBI:CHEBI:57337;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31121;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3S)-hydroxyhexadecanoyl-CoA + NAD(+) = 3-oxohexadecanoyl-CoA
CC         + H(+) + NADH; Xref=Rhea:RHEA:31159, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57349, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:62613; Evidence={ECO:0000269|PubMed:15060085};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31160;
CC         Evidence={ECO:0000269|PubMed:15060085};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3S)-hydroxyhexadecanoyl-CoA = (2E)-hexadecenoyl-CoA + H2O;
CC         Xref=Rhea:RHEA:31163, ChEBI:CHEBI:15377, ChEBI:CHEBI:61526,
CC         ChEBI:CHEBI:62613; Evidence={ECO:0000269|PubMed:15060085};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31165;
CC         Evidence={ECO:0000269|PubMed:15060085};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-hexadecenedioyl-CoA + H2O = (3S)-hydroxyhexadecanedioyl-
CC         CoA; Xref=Rhea:RHEA:40259, ChEBI:CHEBI:15377, ChEBI:CHEBI:77075,
CC         ChEBI:CHEBI:77080; Evidence={ECO:0000269|PubMed:15060085};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40260;
CC         Evidence={ECO:0000269|PubMed:15060085};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3S)-hydroxyhexadecanedioyl-CoA + NAD(+) = 3-
CC         oxohexadecanedioyl-CoA + H(+) + NADH; Xref=Rhea:RHEA:40267,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:77080, ChEBI:CHEBI:77081;
CC         Evidence={ECO:0000269|PubMed:15060085};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40268;
CC         Evidence={ECO:0000269|PubMed:15060085};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3E,5Z)-tetradecadienoyl-CoA = (2E,5Z)-tetradecadienoyl-CoA;
CC         Xref=Rhea:RHEA:47464, ChEBI:CHEBI:71586, ChEBI:CHEBI:87701;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:47466;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3E,5Z)-octadienoyl-CoA = (2E,5Z)-octadienoyl-CoA;
CC         Xref=Rhea:RHEA:49932, ChEBI:CHEBI:85108, ChEBI:CHEBI:131990;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:49934;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3S)-hydroxydecanoyl-CoA + NAD(+) = 3-oxodecanoyl-CoA + H(+) +
CC         NADH; Xref=Rhea:RHEA:31187, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:62548, ChEBI:CHEBI:62616;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31188;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3E)-decenoyl-CoA = (2E)-decenoyl-CoA; Xref=Rhea:RHEA:45752,
CC         ChEBI:CHEBI:61406, ChEBI:CHEBI:84793;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45753;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3Z)-hexenoyl-CoA = (2E)-hexenoyl-CoA; Xref=Rhea:RHEA:45748,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:85415;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45749;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3E)-hexenoyl-CoA = (2E)-hexenoyl-CoA; Xref=Rhea:RHEA:45736,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:84790;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45737;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3S)-hydroxydecanoyl-CoA = (2E)-decenoyl-CoA + H2O;
CC         Xref=Rhea:RHEA:31191, ChEBI:CHEBI:15377, ChEBI:CHEBI:61406,
CC         ChEBI:CHEBI:62616; Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31193;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3S)-hydroxyhexanoyl-CoA = (2E)-hexenoyl-CoA + H2O;
CC         Xref=Rhea:RHEA:30547, ChEBI:CHEBI:15377, ChEBI:CHEBI:62075,
CC         ChEBI:CHEBI:62077; Evidence={ECO:0000250|UniProtKB:P07896};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:30549;
CC         Evidence={ECO:0000250|UniProtKB:P07896};
CC   -!- ACTIVITY REGULATION: Enzyme activity enhanced by acetylation.
CC       {ECO:0000269|PubMed:20167786}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.3 uM for (3S)-hydroxyhexadecanedioyl-CoA
CC         {ECO:0000269|PubMed:15060085};
CC         KM=10 uM for (3S)-hydroxyhexadecanoyl-CoA
CC         {ECO:0000269|PubMed:15060085};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:15060085}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P07896}.
CC   -!- INTERACTION:
CC       Q08426; Q5JTZ9: AARS2; NbExp=3; IntAct=EBI-2339219, EBI-308736;
CC       Q08426; P60709: ACTB; NbExp=4; IntAct=EBI-2339219, EBI-353944;
CC       Q08426; P63261: ACTG1; NbExp=4; IntAct=EBI-2339219, EBI-351292;
CC       Q08426; P78563-4: ADARB1; NbExp=3; IntAct=EBI-2339219, EBI-12002366;
CC       Q08426; Q8N2N9-4: ANKRD36B; NbExp=3; IntAct=EBI-2339219, EBI-12170453;
CC       Q08426; Q5T9G4-2: ARMC12; NbExp=3; IntAct=EBI-2339219, EBI-23667468;
CC       Q08426; Q9UH62: ARMCX3; NbExp=3; IntAct=EBI-2339219, EBI-717832;
CC       Q08426; O14503: BHLHE40; NbExp=3; IntAct=EBI-2339219, EBI-711810;
CC       Q08426; Q8N9W6-4: BOLL; NbExp=3; IntAct=EBI-2339219, EBI-11983447;
CC       Q08426; Q9BV19: C1orf50; NbExp=3; IntAct=EBI-2339219, EBI-2874661;
CC       Q08426; P20807-4: CAPN3; NbExp=3; IntAct=EBI-2339219, EBI-11532021;
CC       Q08426; P35520: CBS; NbExp=4; IntAct=EBI-2339219, EBI-740135;
CC       Q08426; Q68D86: CCDC102B; NbExp=4; IntAct=EBI-2339219, EBI-10171570;
CC       Q08426; Q8IYE1: CCDC13; NbExp=3; IntAct=EBI-2339219, EBI-10961312;
CC       Q08426; Q86X02: CDR2L; NbExp=3; IntAct=EBI-2339219, EBI-11063830;
CC       Q08426; Q9Y592-2: CEP83; NbExp=3; IntAct=EBI-2339219, EBI-11123098;
CC       Q08426; Q9Y281: CFL2; NbExp=3; IntAct=EBI-2339219, EBI-351218;
CC       Q08426; Q8N5K1: CISD2; NbExp=3; IntAct=EBI-2339219, EBI-1045797;
CC       Q08426; P56856: CLDN18; NbExp=3; IntAct=EBI-2339219, EBI-16354902;
CC       Q08426; O00501: CLDN5; NbExp=3; IntAct=EBI-2339219, EBI-18400628;
CC       Q08426; P49760: CLK2; NbExp=3; IntAct=EBI-2339219, EBI-750020;
CC       Q08426; Q9NX76: CMTM6; NbExp=3; IntAct=EBI-2339219, EBI-1054315;
CC       Q08426; O75208: COQ9; NbExp=3; IntAct=EBI-2339219, EBI-724524;
CC       Q08426; P49447: CYB561; NbExp=3; IntAct=EBI-2339219, EBI-8646596;
CC       Q08426; Q8NBI2: CYB561A3; NbExp=3; IntAct=EBI-2339219, EBI-10269179;
CC       Q08426; Q96Q80: DERL3; NbExp=3; IntAct=EBI-2339219, EBI-12831318;
CC       Q08426; P17661: DES; NbExp=6; IntAct=EBI-2339219, EBI-1055572;
CC       Q08426; Q9NR28: DIABLO; NbExp=3; IntAct=EBI-2339219, EBI-517508;
CC       Q08426; Q15125: EBP; NbExp=3; IntAct=EBI-2339219, EBI-3915253;
CC       Q08426; P54849: EMP1; NbExp=3; IntAct=EBI-2339219, EBI-4319440;
CC       Q08426; Q969X5: ERGIC1; NbExp=3; IntAct=EBI-2339219, EBI-781527;
CC       Q08426; Q9Y282: ERGIC3; NbExp=3; IntAct=EBI-2339219, EBI-781551;
CC       Q08426; P60508: ERVFRD-1; NbExp=3; IntAct=EBI-2339219, EBI-17973325;
CC       Q08426; Q92915-2: FGF14; NbExp=3; IntAct=EBI-2339219, EBI-12836320;
CC       Q08426; Q8IVP5: FUNDC1; NbExp=4; IntAct=EBI-2339219, EBI-3059266;
CC       Q08426; O95995: GAS8; NbExp=3; IntAct=EBI-2339219, EBI-1052570;
CC       Q08426; Q96IK5: GMCL1; NbExp=3; IntAct=EBI-2339219, EBI-2548508;
CC       Q08426; Q4V328: GRIPAP1; NbExp=3; IntAct=EBI-2339219, EBI-717919;
CC       Q08426; Q8IV36: HID1; NbExp=3; IntAct=EBI-2339219, EBI-743438;
CC       Q08426; O00291: HIP1; NbExp=3; IntAct=EBI-2339219, EBI-473886;
CC       Q08426; Q9NP66: HMG20A; NbExp=3; IntAct=EBI-2339219, EBI-740641;
CC       Q08426; Q8NBQ5: HSD17B11; NbExp=3; IntAct=EBI-2339219, EBI-1052304;
CC       Q08426; Q9BUP3-3: HTATIP2; NbExp=3; IntAct=EBI-2339219, EBI-12937691;
CC       Q08426; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-2339219, EBI-747204;
CC       Q08426; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-2339219, EBI-10266796;
CC       Q08426; Q8NC69: KCTD6; NbExp=5; IntAct=EBI-2339219, EBI-2511344;
CC       Q08426; Q7L273: KCTD9; NbExp=4; IntAct=EBI-2339219, EBI-4397613;
CC       Q08426; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-2339219, EBI-10172290;
CC       Q08426; Q9BYQ6: KRTAP4-11; NbExp=3; IntAct=EBI-2339219, EBI-10302392;
CC       Q08426; P80188: LCN2; NbExp=3; IntAct=EBI-2339219, EBI-11911016;
CC       Q08426; O95214: LEPROTL1; NbExp=5; IntAct=EBI-2339219, EBI-750776;
CC       Q08426; P36941: LTBR; NbExp=3; IntAct=EBI-2339219, EBI-3509981;
CC       Q08426; Q6UWN5: LYPD5; NbExp=3; IntAct=EBI-2339219, EBI-17200970;
CC       Q08426; Q9NQ48: LZTFL1; NbExp=3; IntAct=EBI-2339219, EBI-2824799;
CC       Q08426; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-2339219, EBI-741037;
CC       Q08426; Q8N8X9: MAB21L3; NbExp=3; IntAct=EBI-2339219, EBI-10268010;
CC       Q08426; O15344: MID1; NbExp=8; IntAct=EBI-2339219, EBI-2340316;
CC       Q08426; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-2339219, EBI-11522433;
CC       Q08426; Q96RE7: NACC1; NbExp=3; IntAct=EBI-2339219, EBI-7950997;
CC       Q08426; Q7Z6G3-2: NECAB2; NbExp=3; IntAct=EBI-2339219, EBI-10172876;
CC       Q08426; P35372-10: OPRM1; NbExp=3; IntAct=EBI-2339219, EBI-12807478;
CC       Q08426; Q9P0S3: ORMDL1; NbExp=3; IntAct=EBI-2339219, EBI-1054848;
CC       Q08426; Q8TEZ7: PAQR8; NbExp=3; IntAct=EBI-2339219, EBI-12847818;
CC       Q08426; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-2339219, EBI-79165;
CC       Q08426; Q8ND90: PNMA1; NbExp=3; IntAct=EBI-2339219, EBI-302345;
CC       Q08426; Q96PV4: PNMA5; NbExp=3; IntAct=EBI-2339219, EBI-10171633;
CC       Q08426; Q9BZL4: PPP1R12C; NbExp=3; IntAct=EBI-2339219, EBI-721802;
CC       Q08426; O75569: PRKRA; NbExp=3; IntAct=EBI-2339219, EBI-713955;
CC       Q08426; O14744: PRMT5; NbExp=3; IntAct=EBI-2339219, EBI-351098;
CC       Q08426; Q1KLZ0: PS1TP5BP1; NbExp=3; IntAct=EBI-2339219, EBI-9978131;
CC       Q08426; O43586: PSTPIP1; NbExp=3; IntAct=EBI-2339219, EBI-1050964;
CC       Q08426; O14684: PTGES; NbExp=3; IntAct=EBI-2339219, EBI-11161398;
CC       Q08426; Q96HR9-2: REEP6; NbExp=3; IntAct=EBI-2339219, EBI-14065960;
CC       Q08426; Q04864-2: REL; NbExp=3; IntAct=EBI-2339219, EBI-10829018;
CC       Q08426; P78317: RNF4; NbExp=3; IntAct=EBI-2339219, EBI-2340927;
CC       Q08426; Q9NS64: RPRM; NbExp=3; IntAct=EBI-2339219, EBI-1052363;
CC       Q08426; Q96GQ5: RUSF1; NbExp=3; IntAct=EBI-2339219, EBI-8636004;
CC       Q08426; Q6ZMJ2-2: SCARA5; NbExp=3; IntAct=EBI-2339219, EBI-12823227;
CC       Q08426; Q8N3Y7: SDR16C5; NbExp=3; IntAct=EBI-2339219, EBI-3923480;
CC       Q08426; Q8WV19: SFT2D1; NbExp=3; IntAct=EBI-2339219, EBI-2854842;
CC       Q08426; Q16585: SGCB; NbExp=3; IntAct=EBI-2339219, EBI-5663627;
CC       Q08426; Q15849: SLC14A2; NbExp=3; IntAct=EBI-2339219, EBI-1573290;
CC       Q08426; Q9NP94: SLC39A2; NbExp=3; IntAct=EBI-2339219, EBI-12898013;
CC       Q08426; Q71RC9: SMIM5; NbExp=3; IntAct=EBI-2339219, EBI-12334905;
CC       Q08426; Q16637: SMN2; NbExp=3; IntAct=EBI-2339219, EBI-395421;
CC       Q08426; Q8WWF3: SSMEM1; NbExp=3; IntAct=EBI-2339219, EBI-17280858;
CC       Q08426; O43805: SSNA1; NbExp=4; IntAct=EBI-2339219, EBI-2515299;
CC       Q08426; Q9Y2D8: SSX2IP; NbExp=3; IntAct=EBI-2339219, EBI-2212028;
CC       Q08426; O43759-2: SYNGR1; NbExp=3; IntAct=EBI-2339219, EBI-12187159;
CC       Q08426; O43761: SYNGR3; NbExp=3; IntAct=EBI-2339219, EBI-11321949;
CC       Q08426; Q9BTD3: TMEM121; NbExp=3; IntAct=EBI-2339219, EBI-12155101;
CC       Q08426; Q86X19: TMEM17; NbExp=3; IntAct=EBI-2339219, EBI-11343485;
CC       Q08426; Q53FP2: TMEM35A; NbExp=3; IntAct=EBI-2339219, EBI-11722971;
CC       Q08426; Q15025: TNIP1; NbExp=4; IntAct=EBI-2339219, EBI-357849;
CC       Q08426; P29144: TPP2; NbExp=5; IntAct=EBI-2339219, EBI-1044672;
CC       Q08426; Q13077: TRAF1; NbExp=3; IntAct=EBI-2339219, EBI-359224;
CC       Q08426; Q12933: TRAF2; NbExp=3; IntAct=EBI-2339219, EBI-355744;
CC       Q08426; P19474: TRIM21; NbExp=3; IntAct=EBI-2339219, EBI-81290;
CC       Q08426; P36406: TRIM23; NbExp=3; IntAct=EBI-2339219, EBI-740098;
CC       Q08426; P14373: TRIM27; NbExp=6; IntAct=EBI-2339219, EBI-719493;
CC       Q08426; Q8WV44: TRIM41; NbExp=7; IntAct=EBI-2339219, EBI-725997;
CC       Q08426; Q9C035-3: TRIM5; NbExp=3; IntAct=EBI-2339219, EBI-12840050;
CC       Q08426; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-2339219, EBI-2130429;
CC       Q08426; Q969Q1: TRIM63; NbExp=3; IntAct=EBI-2339219, EBI-5661333;
CC       Q08426; Q04323-2: UBXN1; NbExp=3; IntAct=EBI-2339219, EBI-11530712;
CC       Q08426; Q08AM6: VAC14; NbExp=3; IntAct=EBI-2339219, EBI-2107455;
CC       Q08426; Q96DT7-3: ZBTB10; NbExp=3; IntAct=EBI-2339219, EBI-12017160;
CC       Q08426; Q9HCK0: ZBTB26; NbExp=5; IntAct=EBI-2339219, EBI-3918996;
CC       Q08426; Q96BR9: ZBTB8A; NbExp=3; IntAct=EBI-2339219, EBI-742740;
CC       Q08426; Q96C00: ZBTB9; NbExp=6; IntAct=EBI-2339219, EBI-395708;
CC       Q08426; Q9NP64: ZCCHC17; NbExp=3; IntAct=EBI-2339219, EBI-746345;
CC       Q08426; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-2339219, EBI-527853;
CC       Q08426; P0DTC9: N; Xeno; NbExp=4; IntAct=EBI-2339219, EBI-25475856;
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q08426-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q08426-2; Sequence=VSP_042811;
CC   -!- TISSUE SPECIFICITY: Liver and kidney. Strongly expressed in the
CC       terminal segments of the proximal tubule. Lower amounts seen in the
CC       brain. {ECO:0000269|PubMed:24401050, ECO:0000269|PubMed:8188243}.
CC   -!- PTM: Acetylated, leading to enhanced enzyme activity. Acetylation is
CC       enhanced by up to 80% after treatment either with trichostin A (TSA) or
CC       with nicotinamide (NAM) with highest increase on Lys-346. Acetylation
CC       and enzyme activity increased by about 1.5% on addition of fatty acids.
CC       {ECO:0000269|PubMed:20167786}.
CC   -!- DISEASE: Fanconi renotubular syndrome 3 (FRTS3) [MIM:615605]: A form of
CC       Fanconi renotubular syndrome, a disease due to a generalized
CC       dysfunction of the proximal kidney tubule resulting in decreased solute
CC       and water reabsorption. Patients have polydipsia and polyuria with
CC       phosphaturia, glycosuria and aminoaciduria. They may develop
CC       hypophosphatemic rickets or osteomalacia, acidosis and a tendency
CC       toward dehydration. Some eventually develop renal insufficiency. FRTS3
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:24401050}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- MISCELLANEOUS: Absent in patients suffering with peroxisomal disorders
CC       such as Zellweger syndrome, neonatal adrenoleukodystrophy and infantile
CC       Refsum disease.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the enoyl-CoA
CC       hydratase/isomerase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the 3-hydroxyacyl-CoA
CC       dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L07077; AAA53289.1; -; mRNA.
DR   EMBL; AJ427345; CAD22483.1; -; Genomic_DNA.
DR   EMBL; AJ427346; CAD22483.1; JOINED; Genomic_DNA.
DR   EMBL; AJ427347; CAD22483.1; JOINED; Genomic_DNA.
DR   EMBL; AJ427348; CAD22483.1; JOINED; Genomic_DNA.
DR   EMBL; AJ427349; CAD22483.1; JOINED; Genomic_DNA.
DR   EMBL; AJ427350; CAD22483.1; JOINED; Genomic_DNA.
DR   EMBL; AJ427351; CAD22483.1; JOINED; Genomic_DNA.
DR   EMBL; AK291798; BAF84487.1; -; mRNA.
DR   EMBL; AK223460; BAD97180.1; -; mRNA.
DR   EMBL; AK301521; BAG63025.1; -; mRNA.
DR   EMBL; AC007934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128680; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78229.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78230.1; -; Genomic_DNA.
DR   EMBL; BC038948; AAH38948.1; -; mRNA.
DR   EMBL; BC110460; AAI10461.1; -; mRNA.
DR   EMBL; S50245; AAB19482.1; -; mRNA.
DR   CCDS; CCDS33901.1; -. [Q08426-1]
DR   CCDS; CCDS54694.1; -. [Q08426-2]
DR   PIR; A49613; A49613.
DR   RefSeq; NP_001159887.1; NM_001166415.1. [Q08426-2]
DR   RefSeq; NP_001957.2; NM_001966.3. [Q08426-1]
DR   RefSeq; XP_011510819.1; XM_011512517.1.
DR   AlphaFoldDB; Q08426; -.
DR   SMR; Q08426; -.
DR   BioGRID; 108282; 153.
DR   IntAct; Q08426; 122.
DR   STRING; 9606.ENSP00000231887; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000000543; -.
DR   iPTMnet; Q08426; -.
DR   PhosphoSitePlus; Q08426; -.
DR   SwissPalm; Q08426; -.
DR   BioMuta; EHHADH; -.
DR   DMDM; 223590229; -.
DR   EPD; Q08426; -.
DR   jPOST; Q08426; -.
DR   MassIVE; Q08426; -.
DR   MaxQB; Q08426; -.
DR   PaxDb; Q08426; -.
DR   PeptideAtlas; Q08426; -.
DR   ProteomicsDB; 58608; -. [Q08426-1]
DR   ProteomicsDB; 58609; -. [Q08426-2]
DR   Antibodypedia; 33832; 371 antibodies from 30 providers.
DR   DNASU; 1962; -.
DR   Ensembl; ENST00000231887.8; ENSP00000231887.3; ENSG00000113790.11. [Q08426-1]
DR   Ensembl; ENST00000456310.5; ENSP00000387746.1; ENSG00000113790.11. [Q08426-2]
DR   GeneID; 1962; -.
DR   KEGG; hsa:1962; -.
DR   MANE-Select; ENST00000231887.8; ENSP00000231887.3; NM_001966.4; NP_001957.2.
DR   UCSC; uc003fpf.3; human. [Q08426-1]
DR   AGR; HGNC:3247; -.
DR   CTD; 1962; -.
DR   DisGeNET; 1962; -.
DR   GeneCards; EHHADH; -.
DR   HGNC; HGNC:3247; EHHADH.
DR   HPA; ENSG00000113790; Group enriched (kidney, liver).
DR   MalaCards; EHHADH; -.
DR   MIM; 607037; gene.
DR   MIM; 615605; phenotype.
DR   neXtProt; NX_Q08426; -.
DR   OpenTargets; ENSG00000113790; -.
DR   Orphanet; 300; Bifunctional enzyme deficiency.
DR   Orphanet; 3337; Primary Fanconi renotubular syndrome.
DR   PharmGKB; PA27682; -.
DR   VEuPathDB; HostDB:ENSG00000113790; -.
DR   eggNOG; KOG1683; Eukaryota.
DR   GeneTree; ENSGT00940000157516; -.
DR   HOGENOM; CLU_009834_16_3_1; -.
DR   InParanoid; Q08426; -.
DR   OMA; TGAGWPF; -.
DR   OrthoDB; 622692at2759; -.
DR   PhylomeDB; Q08426; -.
DR   TreeFam; TF316708; -.
DR   BioCyc; MetaCyc:HS03720-MON; -.
DR   PathwayCommons; Q08426; -.
DR   Reactome; R-HSA-390247; Beta-oxidation of very long chain fatty acids.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   SABIO-RK; Q08426; -.
DR   SignaLink; Q08426; -.
DR   UniPathway; UPA00659; -.
DR   BioGRID-ORCS; 1962; 13 hits in 1164 CRISPR screens.
DR   ChiTaRS; EHHADH; human.
DR   GenomeRNAi; 1962; -.
DR   Pharos; Q08426; Tbio.
DR   PRO; PR:Q08426; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q08426; protein.
DR   Bgee; ENSG00000113790; Expressed in right lobe of liver and 160 other tissues.
DR   ExpressionAtlas; Q08426; baseline and differential.
DR   Genevisible; Q08426; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0004165; F:delta(3)-delta(2)-enoyl-CoA isomerase activity; ISS:UniProtKB.
DR   GO; GO:0004300; F:enoyl-CoA hydratase activity; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0016863; F:intramolecular oxidoreductase activity, transposing C=C bonds; ISS:UniProtKB.
DR   GO; GO:0016509; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0070403; F:NAD+ binding; IEA:InterPro.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome.
DR   CDD; cd06558; crotonase-like; 1.
DR   Gene3D; 1.10.1040.50; -; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR006180; 3-OHacyl-CoA_DH_CS.
DR   InterPro; IPR006176; 3-OHacyl-CoA_DH_NAD-bd.
DR   InterPro; IPR006108; 3HC_DH_C.
DR   InterPro; IPR008927; 6-PGluconate_DH-like_C_sf.
DR   InterPro; IPR029045; ClpP/crotonase-like_dom_sf.
DR   InterPro; IPR018376; Enoyl-CoA_hyd/isom_CS.
DR   InterPro; IPR001753; Enoyl-CoA_hydra/iso.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   PANTHER; PTHR23309; 3-HYDROXYACYL-COA DEHYROGENASE; 1.
DR   PANTHER; PTHR23309:SF49; PEROXISOMAL BIFUNCTIONAL ENZYME; 1.
DR   Pfam; PF00725; 3HCDH; 2.
DR   Pfam; PF02737; 3HCDH_N; 1.
DR   Pfam; PF00378; ECH_1; 1.
DR   SUPFAM; SSF48179; 6-phosphogluconate dehydrogenase C-terminal domain-like; 2.
DR   SUPFAM; SSF52096; ClpP/crotonase; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00067; 3HCDH; 1.
DR   PROSITE; PS00166; ENOYL_COA_HYDRATASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Disease variant; Fatty acid metabolism;
KW   Isomerase; Lipid metabolism; Lyase; Multifunctional enzyme; NAD;
KW   Oxidoreductase; Peroxisome; Phosphoprotein; Reference proteome.
FT   CHAIN           1..723
FT                   /note="Peroxisomal bifunctional enzyme"
FT                   /id="PRO_0000109247"
FT   REGION          1..282
FT                   /note="Enoyl-CoA hydratase / isomerase"
FT   REGION          283..572
FT                   /note="3-hydroxyacyl-CoA dehydrogenase"
FT   MOTIF           721..723
FT                   /note="Microbody targeting signal"
FT   BINDING         101
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            104
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250"
FT   SITE            124
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         38
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         165
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20167786"
FT   MOD_RES         165
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         171
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:20167786"
FT   MOD_RES         219
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         219
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         250
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         280
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         290
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         346
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:20167786"
FT   MOD_RES         350
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         464
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         532
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         548
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         577
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         584
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20167786,
FT                   ECO:0007744|PubMed:19608861"
FT   MOD_RES         584
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         591
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         591
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         710
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         710
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   MOD_RES         718
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         722
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBM2"
FT   VAR_SEQ         1..96
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042811"
FT   VARIANT         3
FT                   /note="E -> K (in FRTS3; the mutant is mistargeted to
FT                   mitochondria; results in impaired mitochondrial oxidative
FT                   phosphorylation and defects in the transport of fluids
FT                   across the epithelium of renal proximal tubular cells;
FT                   dbSNP:rs398124646)"
FT                   /evidence="ECO:0000269|PubMed:24401050"
FT                   /id="VAR_070949"
FT   VARIANT         40
FT                   /note="V -> G (in dbSNP:rs1062551)"
FT                   /evidence="ECO:0000269|PubMed:8188243"
FT                   /id="VAR_054329"
FT   VARIANT         41
FT                   /note="I -> R (in dbSNP:rs1062552)"
FT                   /evidence="ECO:0000269|PubMed:8188243"
FT                   /id="VAR_054330"
FT   VARIANT         75
FT                   /note="T -> I (in dbSNP:rs1062553)"
FT                   /evidence="ECO:0000269|PubMed:8188243"
FT                   /id="VAR_047132"
FT   VARIANT         274
FT                   /note="A -> T (in dbSNP:rs2302819)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_047133"
FT   VARIANT         325
FT                   /note="A -> G (in dbSNP:rs1062555)"
FT                   /evidence="ECO:0000269|PubMed:8188243"
FT                   /id="VAR_054331"
FT   VARIANT         598
FT                   /note="K -> T (in dbSNP:rs1042437)"
FT                   /evidence="ECO:0000269|PubMed:1651711,
FT                   ECO:0000269|PubMed:8188243"
FT                   /id="VAR_054332"
FT   VARIANT         606
FT                   /note="T -> P (in dbSNP:rs1042438)"
FT                   /evidence="ECO:0000269|PubMed:1651711,
FT                   ECO:0000269|PubMed:8188243"
FT                   /id="VAR_047134"
FT   VARIANT         685
FT                   /note="Q -> K (in dbSNP:rs11919970)"
FT                   /id="VAR_047135"
FT   VARIANT         715
FT                   /note="L -> S (in dbSNP:rs11927618)"
FT                   /id="VAR_047136"
FT   MUTAGEN         165
FT                   /note="K->Q: Greatly reduced acetylation and insensitive to
FT                   treatment with TSA and NAM; when associated with Q-171;
FT                   Q-346 and Q-584."
FT                   /evidence="ECO:0000269|PubMed:20167786"
FT   MUTAGEN         171
FT                   /note="K->Q: Greatly reduced acetylation and insensitive to
FT                   treatment with TSA and NAM; when associated with Q-165;
FT                   Q-346 and Q-584."
FT                   /evidence="ECO:0000269|PubMed:20167786"
FT   MUTAGEN         346
FT                   /note="K->Q: Greatly reduced acetylation and insensitive to
FT                   treatment with TSA and NAM; when associated with Q-165;
FT                   Q-171 and Q-584."
FT                   /evidence="ECO:0000269|PubMed:20167786"
FT   MUTAGEN         584
FT                   /note="K->Q: Greatly reduced acetylation and insensitive to
FT                   treatment with TSA and NAM; when associated with Q-165;
FT                   Q-171 and Q-346."
FT                   /evidence="ECO:0000269|PubMed:20167786"
FT   CONFLICT        117
FT                   /note="E -> D (in Ref. 1; AAA53289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        656..657
FT                   /note="WP -> CA (in Ref. 1; AAA53289 and 7; AAB19482)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   723 AA;  79495 MW;  FC3B44B030A7BCBD CRC64;
     MAEYTRLHNA LALIRLRNPP VNAISTTLLR DIKEGLQKAV IDHTIKAIVI CGAEGKFSAG
     ADIRGFSAPR TFGLTLGHVV DEIQRNEKPV VAAIQGMAFG GGLELALGCH YRIAHAEAQV
     GLPEVTLGLL PGARGTQLLP RLTGVPAALD LITSGRRILA DEALKLGILD KVVNSDPVEE
     AIRFAQRVSD QPLESRRLCN KPIQSLPNMD SIFSEALLKM RRQHPGCLAQ EACVRAVQAA
     VQYPYEVGIK KEEELFLYLL QSGQARALQY AFFAERKANK WSTPSGASWK TASARPVSSV
     GVVGLGTMGR GIVISFARAR IPVIAVDSDK NQLATANKMI TSVLEKEASK MQQSGHPWSG
     PKPRLTSSVK ELGGVDLVIE AVFEEMSLKK QVFAELSAVC KPEAFLCTNT SALDVDEIAS
     STDRPHLVIG THFFSPAHVM KLLEVIPSQY SSPTTIATVM NLSKKIKKIG VVVGNCFGFV
     GNRMLNPYYN QAYFLLEEGS KPEEVDQVLE EFGFKMGPFR VSDLAGLDVG WKSRKGQGLT
     GPTLLPGTPA RKRGNRRYCP IPDVLCELGR FGQKTGKGWY QYDKPLGRIH KPDPWLSKFL
     SRYRKTHHIE PRTISQDEIL ERCLYSLINE AFRILGEGIA ASPEHIDVVY LHGYGWPRHK
     GGPMFYASTV GLPTVLEKLQ KYYRQNPDIP QLEPSDYLKK LASQGNPPLK EWQSLAGSPS
     SKL
//
